Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H30NO3 |
| Molecular Weight | 368.4892 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 1 |
SHOW SMILES / InChI
SMILES
CC[N+]3(CCOC(=O)C(O)(C1=CC=CC=C1)C2=CC=CC=C2)CCCCC3
InChI
InChIKey=OHEDKBMQRCAABJ-UHFFFAOYSA-N
InChI=1S/C23H30NO3/c1-2-24(16-10-5-11-17-24)18-19-27-22(25)23(26,20-12-6-3-7-13-20)21-14-8-4-9-15-21/h3-4,6-9,12-15,26H,2,5,10-11,16-19H2,1H3/q+1
DescriptionCurator's Comment: description was created based on several sources, including
https://www.drugs.com/international/pipethanate-ethobromide.html | http://www.druginfosys.com/drug.aspx?drugcode=2164&type=1 | https://www.ncbi.nlm.nih.gov/pubmed/5170094 | http://www.rjbc.ru/arc/11/10/1402-1416.pdf | https://www.ncbi.nlm.nih.gov/pubmed/5170093
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/pipethanate-ethobromide.html | http://www.druginfosys.com/drug.aspx?drugcode=2164&type=1 | https://www.ncbi.nlm.nih.gov/pubmed/5170094 | http://www.rjbc.ru/arc/11/10/1402-1416.pdf | https://www.ncbi.nlm.nih.gov/pubmed/5170093
Pipethanate ethobromide is an antimuscarinic with actions similar to those of atropine. It has been used in the symptomatic treatment of visceral spasms in oral doses of up to 160 mg daily in divided doses. Pipethanate ethobromide has also been given intramuscularly or intravenously in doses of 10 to 20 mg daily and rectally in doses of 60 or 120 mg daily.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2094109 Sources: http://www.rjbc.ru/arc/11/10/1402-1416.pdf |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Epithanate G Approved UseUnknown |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
23795-19-9
Created by
admin on Wed Apr 02 05:22:10 GMT 2025 , Edited by admin on Wed Apr 02 05:22:10 GMT 2025
|
PRIMARY | |||
|
DTXSID7048324
Created by
admin on Wed Apr 02 05:22:10 GMT 2025 , Edited by admin on Wed Apr 02 05:22:10 GMT 2025
|
PRIMARY | |||
|
4841
Created by
admin on Wed Apr 02 05:22:10 GMT 2025 , Edited by admin on Wed Apr 02 05:22:10 GMT 2025
|
PRIMARY | |||
|
5J99GQ69TK
Created by
admin on Wed Apr 02 05:22:10 GMT 2025 , Edited by admin on Wed Apr 02 05:22:10 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD